Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$61.48 - $73.72 $604,840 - $725,257
-9,838 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $527,611 - $615,071
9,838 New
9,838 $610,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Hancock Whitney Investment Services Inc. Portfolio

Follow Hancock Whitney Investment Services Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Investment Services Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Investment Services Inc. with notifications on news.